Ignite Creation Date:
2025-12-24 @ 3:28 PM
Ignite Modification Date:
2026-02-20 @ 4:46 PM
Study NCT ID:
NCT00979992
Status:
COMPLETED
Last Update Posted:
2020-02-19
First Post:
2009-09-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-04-19
Start Date Type:
ACTUAL
Primary Completion Date:
2014-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-09
Completion Date Type:
ACTUAL
First Submit Date:
2009-09-17
First Submit QC Date:
None
Study First Post Date:
2009-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-12-29
Results First Submit QC Date:
None
Results First Post Date:
2017-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-06
Last Update Post Date:
2020-02-19
Last Update Post Date Type:
ACTUAL